Weight Loss
GLP-1 for People Recovering From COVID Long-Haul Weight Gain
About 7% of U.S. adults report current symptoms of long COVID, per CDC Household Pulse Survey data from 2024.
GLP-1 for People on Antipsychotic Medications
Antipsychotic-induced weight gain is one of the most well-documented and difficult-to-manage adverse effects in psychiatry.
GLP-1 and Depression: Can Weight Loss Medication Help?
The question of whether semaglutide and tirzepatide affect depression has gotten messier rather than cleaner.
GLP-1 and ADHD: Emerging Research on Impulse Control & Weight
People with ADHD are 40 to 70% more likely to be obese than people without it. The reasons are tangled.
GLP-1 and Addiction: How Weight Loss Drugs May Curb Substance Use
The first stories were anecdotal.
Exenatide Real Results: Weight Loss Timeline and What Patients Report
Exenatide produces real but modest results compared with newer GLP-1 drugs.
The Endocrine System and Weight: How Hormones Control Everything
If body weight were just calories in and calories out, weight loss would be a math problem. It is not.
Efinopegdutide Real Results: Weight Loss Timeline & What Patients Report
Introduction Efinopegdutide’s main published efficacy data comes from the Romero-Gomez 2023 Journal of Hepatology phase 2a trial: 145 adults with MASH-related liver fat (MRI-PDFF…
The Economics of Obesity: Why GLP-1 Medications Pay for Themselves
Obesity is expensive. The CDC estimates the annual medical cost of obesity in the United States at over $173 billion in 2019 dollars.
